How to eradicate Helicobacter pylori infection with patients with digestive ulcer and chronic gastritis, after treatment, after the healing, after a period of recurrence. So what is the reason for recurrence? It is now confirmed by research, and the existence of Helicobacter pylori infection is the main holiday. So did the medical community have found some ideal effective Helicobacterium roots? The answer is yes. At present, three types of treatment programs recommended by clinical treatment are three kinds of trialas with bismuth agents, proton pump inhibitors or Reniti-tin butter, 1 week. Three programs have high Helicobacterigen Roots and the healing rate of ulcers, and less adverse reactions, and the symptom control is rapidly characterized. Since the triump therapy containing the binder is the treatment plan for the long-term use of the clinical time, the effectiveness and safety have been long-term clinical verification, and the treatment cost is the lowest, so it is more suitable for China's national conditions. Traditional Triae Tripotherapy, containing the tenth World Gastrointestinal Diseases, is recommended as a standard plan for Helicobacterigen, but objectively, with the clinical application of Helicobacterium, the bacteria also appears. The problem of drug resistance, especially the resistance to metronidazole, to a large extent, the rootary rate of Helicobacter. At the same time, the application of the scheme is also limited by the incidence of metronidazole and tetracycline adverse reactions. It is grateful that there is currently a combination of combined packaging drugs in accordance with traditional bismuth triple programs - Li Zhu stomach. It consists of 3 drugs (ie, 即 珠 乐), clarithromycin and nitridazole. Each drug has been carefully selected. Li Zhu is rapidly disintegrating a small colloidal substance under the action of gastric acid, closely binding to the ulcer surface to form a protective film, isolating gastric acid, can quickly relieve symptoms. It also promotes the generation of endogenous prostaglandin, improves the amount of mucosa blood flow and mucus, promotes the repair of mucosa, and the drug also has a strong killing of Helicobacter pylori. Triazidazole is a new generation of nitromidazole drugs in the triple programs, which has the advantages of strong antibacterial activity, good bioavailability, good tolerance and side effects. The cyclistin in the triple program is a new generation of large cyclo-ester drugs, which is more stable in the acidic environment. It can have a higher concentration in the stomach, which is the most known antibiotic to the highest effect on Helicobacter. First, with the nitrrazole in combination can significantly improve the hobs of Helicobacter. Lizhu Stomach Tri-Bank is a one-day medication, and three drugs are distinguished in different colors. Among them, the white tablets are Li Zhule 0.22 g / grain, and the green sheet is 0.5 g / grain for the nitronazole tablets, and the yellow sheet is 0.25 g / grain. Li Zhu is 2 times a day, 2 tablets each, half an hour in the evening, half an hour in the morning and evening, ttyzidazole and claws: 2 times a day, 1 tablet each time, take it after a morning and evening; 3 days for the treatment of 1 week . Due to the use of composite packaging, it is conducive to the patient to take, avoid leakage and less, then they inherit the traditional ruthenium three security, effective, low price, and also reduce the drug resistance of Helicobacter, increase the treatment The effectiveness reduces the incidence of adverse reactions during treatment? Clinical trials show that Lizhu Stomatology can receive a higher Helicobacterium root reduction in gastric ulcer, duodenal ulcer and chronic gastritis. In the duodenal ulcer patient, there is only 90.9% of the treatment of the course of the course of treatment in the 12-lypling patient, and the rootary rate of the two-week course is 92.9%; in patients with chronic gastritis, there is a use of Lizhu stomach triple, the treatment rate of the treatment can be achieved in one week. 81.8%, the roots of the two weeks can reach 84%; in patients with gastric ulcer, the use of Li Zhu stomach triple, the roots of the course of treatment can reach 95%. The incidence of adverse reactions in clinical trials is low. A small amount of patients have nausea, diarrhea and other gastrointestinal reactions and dizziness, fatigue, etc., all are slight, unlike the treatment, and the course is relieved after the end of the course.
